CORRECTION
Published on 13 Jun 2022
Corrigendum: Efficacy and Safety of Shenqu Xiaoshi Oral Liquid Compared With Domperidone Syrup in Children With Functional Dyspepsia
doi 10.3389/fphar.2022.920925
- 1,231 views
- 1 citation
- Frontiers in Pharmacology
- Respiratory Pharmacology
- Research Topics
- Fibrosis in the Respiratory and Digestive Systems
Fibrosis in the Respiratory and Digestive Systems
90k
Total downloads
274k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 25 Apr 2022
An Herbal Product Alleviates Bleomycin-Induced Pulmonary Fibrosis in Mice via Regulating NF-κB/TNF-α Signaling in Macrophages
doi 10.3389/fphar.2022.805432
- 2,041 views
- 10 citations
ORIGINAL RESEARCH
Published on 28 Mar 2022
Blueberry Juice Attenuates Pulmonary Fibrosis via Blocking the TGF-β1/Smad Signaling Pathway
doi 10.3389/fphar.2022.825915
- 4,978 views
- 6 citations
REVIEW
Published on 17 Mar 2022
Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis
doi 10.3389/fphar.2022.826471
- 5,606 views
- 12 citations
ORIGINAL RESEARCH
Published on 14 Mar 2022
Dihydromyricetin Alleviates Pulmonary Fibrosis by Regulating Abnormal Fibroblasts Through the STAT3/p-STAT3/GLUT1 Signaling Pathway
doi 10.3389/fphar.2022.834604
- 2,581 views
- 10 citations
ORIGINAL RESEARCH
Published on 09 Mar 2022
ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation
doi 10.3389/fphar.2022.835979
- 3,220 views
- 11 citations
ORIGINAL RESEARCH
Published on 09 Mar 2022
Dec1 Deficiency Ameliorates Pulmonary Fibrosis Through the PI3K/AKT/GSK-3β/β-Catenin Integrated Signaling Pathway
doi 10.3389/fphar.2022.829673
- 4,099 views
- 19 citations
REVIEW
Published on 04 Mar 2022
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review
doi 10.3389/fphar.2022.748931
- 3,681 views
- 36 citations
ORIGINAL RESEARCH
Published on 17 Feb 2022
A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors
doi 10.3389/fimmu.2022.826337
- 13,569 views
- 33 citations
REVIEW
Published on 11 Feb 2022
Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
doi 10.3389/fphar.2022.787748
- 6,423 views
- 46 citations
ORIGINAL RESEARCH
Published on 11 Feb 2022
Exploring the Anti-Pulmonary Fibrosis Mechanism of Jingyin Granule by Network Pharmacology Strategy
doi 10.3389/fphar.2022.825667
- 3,130 views
- 5 citations
ORIGINAL RESEARCH
Published on 10 Feb 2022
Longitudinal and Comparative Measures of Serum Chitotriosidase and YKL-40 in Patients With Idiopathic Pulmonary Fibrosis
doi 10.3389/fimmu.2022.760776
- 1,755 views
- 17 citations
Published in
Frontiers in Pharmacology
Respiratory Pharmacology
Gastrointestinal and Hepatic Pharmacology
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore